Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The specificity and function of T helper (Th) immune responses underlying the induction, progression, and resolution of experimental autoimmune myocarditis (EAM) in A/J mice are unclear. Published data suggest involvement of both Th1 and Th2 responses in EAM; however, the previous inability to assess antigen-specific in vivo and in vitro T-cell responses in cardiac myosin-immunized animals has confounded our understanding of this important model of autoimmune myocarditis. The goal of our study was to develop an alternative model of EAM based on a recombinant fragment of cardiac myosin, in hopes that the recombinant protein will permit measurement of functional T-cell responses that is not possible with purified native protein. A/J mice immunized with a recombinant fragment of cardiac myosin spanning amino acids 1074-1646, termed Myo4, developed severe myocarditis characterized by cardiac hypertrophy, massive mononuclear cell infiltration and fibrosis, three weeks post-immunization. The mice also developed an IgG1 dominant humoral immune response specific for both Myo4 and purified cardiac myosin. The in vitro stimulation of splenocytes harvested from Myo4-immunized animals with Myo4 resulted in cellular proliferation with preferential production of the Th1- and Th17-associated cytokines, IFN-gamma, IL-17, and IL-6, respectively. Production of IL-4 was negligible by comparison. This study describes a new model of EAM, inducible by immunization with a specific fragment of cardiac myosin, from which antigen-specific analyses reveal an importance for both Th1 and Th17 immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From Infection to Autoimmunity
Fairweather, D., Kaya, Z., Shellam, G. R., Lawson, C. M., & Rose, N. R. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0492 · Cited by 328
Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy
Neumann, D. A., Lynne Burek, C., Baughman, K. L., Rose, N. R., & Herskowitz, A. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80331-6 · Cited by 191
Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.
Liao, L., Sindhwani, R., Rojkind, M., Factor, S., Leinwand, L., & Diamond, B. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1123 · Cited by 155 · cited 1×
“The myosinspecific humoral immunity showed a dominance of IgG1 over IgG2a (Figure 3), in agreement with published findings of IgG production in cardiac myosin-immunized A/J mice [21,35] and BALB/c mice [36].”
ResultDonermeyer, D. L., Beisel, K. W., Allen, P. M., & Smith, S. C. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1291 · Cited by 140
Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy.
Goldman, J. H., Keeling, P. J., Warraich, R. S., Baig, M. K., Redwood, S. R., Dalla Libera, L., Sanderson, J. E., Caforio, A. L., & McKenna, W. J. (1995) · Heart · doi:10.1136/hrt.74.6.598 · Cited by 62
Cited by
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230
“Although our evidence supports the presence of the Th17 phenotype as a dominant phenotype of myocarditis/DCM and Th17/IL-17 being associated with nonrecovery and heart failure, conversion of the Th17 phenotype to also express Th1-related IFN-γ may lead to more pathogenic T cells in human disease, as found in mouse mod…”
InfluentialLiu, Y., Zhu, H., Su, Z., Sun, C., Yin, J., Yuan, H., Sandoghchian, S., Jiao, Z., Wang, S., & Xu, H. (2012) · International Immunology · doi:10.1093/intimm/dxs056 · Cited by 110
Gangaplara, A., Massilamany, C., Brown, D. M., Delhon, G., Pattnaik, A. K., Chapman, N., Rose, N., Steffen, D., & Reddy, J. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.07.003 · Cited by 69
“We and others have previously demonstrated that the lymphocytes generated from Myhc-α 334–352-immunized mice contain predominantly IL-17-producing cells [4,19,37].”
Basavalingappa, R. H., Arumugam, R., Lasrado, N., Yalaka, B., Massilamany, C., Gangaplara, A., Riethoven, J.-J., Xiang, S.-H., Steffen, D., & Reddy, J. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.06.017 · Cited by 29
Tada, Y., Ogawa, M., Watanabe, R., Zempo, H., Takamura, C., Suzuki, J.-I., Dan, T., Miyata, T., Isobe, M., & Komuro, I. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.855196 · Cited by 9
Metadata
- Authors
- Daniels, M. D., Hyland, K. V., Wang, K., & Engman, D. M.
- Venue
- Autoimmunity
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 41
- Issue
- 6
- Pages
- 490-499
- ISSN
- 0891-6934 (ISSN-L)
- 1607-842X
- OpenAlex
- W2114192257
- Cited by
- 49
- References
- 5
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. https://app.cochat.ai/papers/10.1080/08916930802167902
- The paper
- Daniels, M. D., Hyland, K. V., Wang, K., & Engman, D. M. (2008). Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. Autoimmunity. https://doi.org/10.1080/08916930802167902
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.